1225218-99-4 Usage
Uses
Used in Pharmaceutical Research:
(S)-Benzyl 3-(pyridin-3-yl)pyrrolidine-1-carboxylate is used as a research compound for its potential antiproliferative and antioxidant properties. Its ability to inhibit cell proliferation and combat oxidative stress makes it a promising candidate for the development of new drugs targeting various diseases and conditions.
Used in Drug Development:
In the drug development industry, (S)-benzyl 3-(pyridin-3-yl)pyrrolidine-1-carboxylate is utilized as a lead compound. Its specific structure and functional groups allow for the exploration of its potential therapeutic applications, which may include the treatment of various illnesses and disorders.
Used in Medicinal Chemistry:
(S)-Benzyl 3-(pyridin-3-yl)pyrrolidine-1-carboxylate serves as a valuable compound in medicinal chemistry. Researchers use it to study its interactions with biological targets and to design new molecules with improved pharmacological properties.
Used in Pharmacology:
In the field of pharmacology, (S)-benzyl 3-(pyridin-3-yl)pyrrolidine-1-carboxylate is employed to investigate its potential effects on biological systems. Understanding its mechanism of action can lead to the development of novel therapeutic strategies and the improvement of existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 1225218-99-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,5,2,1 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1225218-99:
(9*1)+(8*2)+(7*2)+(6*5)+(5*2)+(4*1)+(3*8)+(2*9)+(1*9)=134
134 % 10 = 4
So 1225218-99-4 is a valid CAS Registry Number.
1225218-99-4Relevant academic research and scientific papers
BENZIMIDAZOLE AND AZA-BENZIMIDAZOLE CARBOXAMIDES
-
Page/Page column 55, (2010/05/14)
This invention provides compounds of Formula I which are PAFR antagonists: I and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preve
BIARYL CARBOXAMIDES
-
Page/Page column 56, (2010/08/04)
This invention provides compounds of Formula (I) which are PAFR antagonists: Formula (I) and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preventing or reducing risk for atherosclerotic disease events. The compounds are also useful for treating or ameliorating pain, e.g. inflammatory pain and/or nociceptive pain, and for treating or ameliorating autoimmune and/or inflammatory diseases, among other conditions.
